The effects of a bisquaternary oxamide, methoxyambenonium (Meamb), d-tubocurarine ( d-tbc ), and of an oxime, pyridine-2-aldoxime methiodide (P-2-AM), upon the frog neuromyal junction, treated by organophosphorus anticholinesterases, TEPP and DFP, were studied. The oxamide and d-tbc resembled P-2-AM and other reactivators in that they caused a return of the sustained tetanic response and of the post-tetanic potentiation, after these were blocked by TEPP or DFP. Ringer's solution was did not reverse these actions of the oxamides and of d-tbc . In these actions, these drugs resembled two types of reactivators, NaF and P-2-AM. The well-known marked prolongation of the endplate potential (e.p.p.) by TEPP or DFP was markedly shortened by the oxamide and by d-tbc . The former also increased the amplitude of the e.p.p. These effects were obtained whether the transmission was blocked by Mg or by d-tbc itself. The finding of earlier investigators that d-tbc lowers the amplitude but does not shorten the duration of the e.p.p. was confirmed. P-2-AM antagonized the d-tbc block of the twitch response, increased the amplitude but not the duration of the e.p.p. and augmented but did not prolong acetylcholine depolarization of the e.p. This effect, described in this laboratory as sensitization, and distinct from anticholinesterase action, is shown by several reactivators, oxamides and several other neuromyal facilitators. It is suggested that the actions of the oxamide and of d-tbc upon TEPP or DFP response of the neuromyal junction may be explained by their reactivation capacity. Conversely, reactivators may exhibit sensitizing and facilitating actions.